Monitoring Dose Response of Cyanide Antidote Dimethyl Trisulfide in Rabbits Using Diffuse Optical Spectroscopy
- 221 Downloads
Cyanide (CN) poisoning is a serious chemical threat from accidental or intentional exposures. Current CN exposure treatments, including direct binding agents, methemoglobin donors, and sulfur donors, have several limitations. Dimethyl trisulfide (DMTS) is capable of reacting with CN to form the less toxic thiocyanate with high efficiency, even without the sulfurtransferase rhodanese. We investigated a soluble DMTS formulation with the potential to provide a continuous supply of substrate for CN detoxification which could be delivered via intramuscular (IM) injection in a mass casualty situation. We also used non-invasive technology, diffuse optical spectroscopy (DOS), to monitor physiologic changes associated with CN exposure and reversal.
Thirty-six New Zealand white rabbits were infused with a lethal dose of sodium cyanide solution (20 mg/60 ml normal saline). Animals were divided into three groups and treated with saline, low dose (20 mg), or high dose (150 mg) of DMTS intramuscularly. DOS continuously assessed changes in tissue hemoglobin concentrations and cytochrome c oxidase redox state status throughout the experiment.
IM injection of DMTS increased the survival in lethal CN poisoning. DOS demonstrated that high-dose DMTS (150 mg) reversed the effects of CN exposure on cytochrome c oxidase, while low dose (20 mg) did not fully reverse effects, even in surviving animals.
This study demonstrated potential efficacy for the novel approach of supplying substrate for non-rhodanese mediated sulfur transferase pathways for CN detoxification via intramuscular injection in a moderate size animal model and showed that DOS was useful for optimizing the DMTS treatment.
KeywordsChemical and biological weapons Cyanide toxicity reversal Optical hemodynamic monitoring Dimethyl trisulfide Lethal cyanide poisoning Diffuse optical spectroscopy
Diffuse optical spectroscopy
Cytochrome c oxidase
Compliance with Ethical Standards
All procedures were reviewed and approved by the University of California, Irvine, Institutional Animal Care and Use Committee (IACUC).
Conflict of Interest Statement
This work was supported, in part, by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), and the National Institute of Neurological Disorders and Stroke (NINDS) grant numbers U54 NS0792, U01 NS058030, and U54 NS063718, AMRMC W81XWH-12-2-0098, CounterACT NIH No. 1U54 NS079201 and by the Air Force Office of Scientific Research award numbers FA9550-17-1-0193 and FA9550-14-1-0193, and the Robert A. Welch Foundation (x-001) at Sam Houston State University, Huntsville, TX.
Any opinions, findings, conclusions, or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the United States Air Force.
- 4.Baskin SI, Brewer TG. Medical aspects of chemical and biological warfare. Chapter 10, Cyanide Poisoning. In: Sidell FR, Takafuji ET, Franz DR, Borden Institute (U.S.), editors. Textbook of military medicine. Part I, Warfare, weaponry, and the casualty. Washington, D.C.: Borden Institute, Walter Reed Army Medical Center; Office of the Surgeon General, U.S. Army; U.S. Army Medical Dept. Center and School; U.S. Army Medical Research and Material Command; Uniformed Services University of the Health Sciences; 1997. p. 272–86.Google Scholar
- 5.Hydrogen cyanide, potassium cyanide and sodium cyanide [MAK Value Documentation, 2003]. In: Tschickardt M, editor. The MAK-collection for occupational health and safety. Wiley Online Library; 2012. pp. 193–95. https://doi.org/10.1002/3527600418.mb7490vere0019.
- 6.Wong-Chong GM, Nakles DV, Luthy RG. Manufacture and the use of cyanide. In: Dzombak DA, Ghosh RS, Wong-Chong GM, editors. Cyanide in water and soil: chemistry, risk, and management. Boca Raton: CRC Press; 2006. pp. 41–57.Google Scholar
- 7.Suskind R, editor. The one percent doctrine: deep inside America’s pursuit of its enemies since 9/11. New York: Simon & Schuster; 2006.Google Scholar
- 10.Rockwood GA, Thompson DE, Petrikovics I. Dimethyl trisulfide: a novel cyanide countermeasure. Toxicol Ind Health. 2016;32(12):2009–16. doi:0748233715622713 [pii]Google Scholar
- 11.DeLeon SM, Downey JD, Hildenberger DM, Rhoomes MO, Booker L, Rockwood GA, et al. DMTS is an effective treatment in both inhalation and injection models for cyanide poisoning using unanesthetized mice. Clin Toxicol (Phila). 2018;56(5):332–41. https://doi.org/10.1080/15563650.2017.1376749.CrossRefGoogle Scholar
- 12.Rockwood GA, Petrikovics I, Baskin SI, inventors; Sam Houston State University, US Secretary of Army, assignee. Dimethyl trisulfide as a cyanide antidote. US Patent US9375407B2, 28 June 2016.Google Scholar
- 13.Petrikovics I, Kovacs KI, inventors; Sam Houston State University, assignee. Formulations of dimethyl trisulfide for use as a cyanide antidote. US Patent US9456996B2, 04 Oct 2016.Google Scholar
- 19.Brenner M, Mahon SB, Lee J, Kim J, Mukai D, Goodman S, et al. Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring. J Biomed Opt. 2010;15(1):017001. https://doi.org/10.1117/1.3290816.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Zijlstra WG, Buursma A, Assendelft OW. Visible and near-infrared absorption spectra of human and animal hemoglobin. AH Zeist: VSP BV; 2000.Google Scholar
- 26.Eker C. Optical characterization of tissue for medical diagnostics [Ph.D. dissertation]. Lund: Lund University; 1999.Google Scholar
- 31.Cooper CE, Cope M, Springett R, Amess PN, Penrice J, Tyszczuk L, et al. Use of mitochondrial inhibitors to demonstrate that cytochrome oxidase near-infrared spectroscopy can measure mitochondrial dysfunction noninvasively in the brain. J Cereb Blood Flow Metab. 1999;19(1):27–38.CrossRefGoogle Scholar